Freising-Weihenstephan, Germany

Dominik Hinz



 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Freising, DE (2017)
  • Freising-Weihenstephan, DE (2020 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Dominik Hinz: Innovating in Therapeutic Protein Development**

Introduction

Dominik Hinz is a prominent inventor based in Freising-Weihenstephan, Germany. With a focus on therapeutic proteins, he has successfully secured three patents that bring innovative solutions to significant health challenges. His work, particularly in developing muteins of human lipocalin 2, showcases his commitment to advancing medical science.

Latest Patents

Hinz's most notable inventions include a series of muteins derived from human lipocalin 2 (Lcn2, hNGAL) that demonstrate affinity for specific biological targets. This groundbreaking invention involves a novel library for the generation of these muteins, alongside new nucleic acid molecules that encode them. Specifically, these muteins are designed to bind and remove pathological forms of biomolecules, such as the amyloid beta peptide implicated in Alzheimer's disease, and target fibronectin extra-domain B, which plays a role in tumor neovasculature. These inventions have the potential to significantly impact therapeutic strategies in oncology and neurology.

Career Highlights

Dominik Hinz works at Pieris Pharmaceuticals GmbH, where he contributes his expertise in innovative protein design and development. His role in the research and biotechnology sectors underscores his dedication to improving human health through innovation. The patents he holds reflect his pioneering spirit and technical acumen in the field.

Collaborations

Hinz collaborates with notable individuals in his field, including Arne Skerra and Michaela Gebauer, who enhance the research environment and contribute to the collaborative spirit at Pieris Pharmaceuticals GmbH. These partnerships are vital in driving forward the innovations that aim to transform therapeutic approaches.

Conclusion

In summary, Dominik Hinz is a distinguished inventor whose patents in therapeutic protein development position him at the forefront of biomedical innovation. His work not only illustrates the potential of muteins in addressing complex medical challenges but also highlights the importance of collaborative efforts in advancing scientific discovery. Through his contributions, Hinz continues to shape the landscape of therapeutic solutions, making a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…